A swiss-based company developing therapeutics for chronic inflammation.
We are engineering novel bi-functional Duokine therapeutics, rationally designed to simultaneously target distinct immune cell populations and disease-relevant pathways.

Location
Additional address info
  • Trypto
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2023
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in